Office of the Director, National Institutes of Health; Notice of Meeting, 7988 [2023-02493]
Download as PDF
<![CDATA[
7988
Federal Register / Vol. 88, No. 25 / Tuesday, February 7, 2023 / Notices
ddrumheller on DSK120RN23PROD with NOTICES
should notify the Contact Person listed
below in advance of the meeting. The
meeting will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://
videocast.nih.gov).
Name of Committee: National Cancer
Institute Council of Research Advocates.
Date: March 1, 2023.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: Welcome and Chairwoman’s
Remarks, NCI Director’s Update, NCI Updates
and Legislative Update.
Place: Porter Neuroscience Research
Center, Building 35A, Room 610, 35 Convent
Drive, Bethesda, MD 20892.
Contact Person: Amy Williams, Acting
Director, NCI Office of Advocacy Relations
National Cancer Institute, NIH, 9000
Rockville Pike, Building 31, Room 10A28,
Bethesda, MD 20892, (240) 781–3406,
williaam@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Additional Health and Safety Guidance:
Before attending a meeting at an NIH facility,
it is important that visitors review the NIH
COVID–19 Safety Plan at https://
ors.od.nih.gov/sr/dohs/safety/NIH-covid-19safety-plan/Pages/default.aspx for
information about requirements and
procedures for entering NIH facilities,
especially when COVID–19 community
levels are medium or high. In addition, the
Safer Federal Workforce website has FAQs
for visitors at https://www.saferfederal
workforce.gov/faq/visitors/. Please note that
if an individual has a COVID–19 diagnosis
within 10 days of the meeting, that person
must attend virtually. (For more information
please read NIH’s Requirements for Persons
after Exposure at https://ors.od.nih.gov/sr/
dohs/safety/NIH-covid-19-safety-plan/
COVID-assessment-testing/Pages/personsafter-exposure.aspx and What Happens
When Someone Tests Positive at https://
ors.od.nih.gov/sr/dohs/safety/NIH-covid-19safety-plan/COVID-assessment-testing/Pages/
test-positive.aspx.) Anyone from the public
can attend the open portion of the meeting
virtually via the NIH Videocasting website
(https://videocast.nih.gov). Please continue
checking these websites, in addition to the
committee website listed below, for the most
up to date guidance as the meeting date
approaches.
Information is also available on the
Institute’s/Center’s home page: NCRA: https://
VerDate Sep<11>2014
18:52 Feb 06, 2023
Jkt 259001
deainfo.nci.nih.gov/advisory/ncra/ncra.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 1, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–02495 Filed 2–6–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.oar.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: February 1, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–02493 Filed 2–6–23; 8:45 am]
Office of the Director, National
Institutes of Health; Notice of Meeting
BILLING CODE 4140–01–P
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Office of AIDS Research
Advisory Council.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
will be videocast and can be accessed
from the NIH Videocasting and
Podcasting website (https://
videocast.nih.gov/).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Name of Committee: Office of AIDS
Research Advisory Council.
Date: March 2, 2023.
Time: 11:00 a.m. to 4:30 p.m.
Agenda: The sixty-second meeting of the
Office of AIDS Research Advisory Council
(OARAC) will include the OAR Director’s
Report; presentation and discussions on HIV
and Aging, updates from the Clinical
Guidelines Working Groups of OARAC; an
overview of ARPA–H; updates from NIH
HIV-related advisory councils and NIH-wide
programs; and public comment.
Place: Office of AIDS Research, 5601
Fishers Lane, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Mary Glenshaw, Ph.D.,
MPH, OTR/L, Senior Science Advisor, Office
of AIDS Research, Office of the Director,
National Institutes of Health, 5601 Fishers
Lane, Room 2E61, Rockville, MD 20852,
(301) 496–0357, OARACInfo@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; BRAIN Initiative: TeamResearch BRAIN Circuits U19 Review.
Date: February 26-March 1, 2023.
Time: 6:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Canopy by Hilton, 940 Rose Avenue,
North Bethesda, MD 20852.
Contact Person: Tatiana Pasternak, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
NINDS/NIH, NSC, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892,
301–496–9223, tatiana.pasternak@nih.gov.
E:\FR\FM\07FEN1.SGM
07FEN1
]]>Agencies
[Federal Register Volume 88, Number 25 (Tuesday, February 7, 2023)]
[Notices]
[Page 7988]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-02493]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Office of AIDS
Research Advisory Council.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting. The meeting will be videocast and can be
accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov/).
Name of Committee: Office of AIDS Research Advisory Council.
Date: March 2, 2023.
Time: 11:00 a.m. to 4:30 p.m.
Agenda: The sixty-second meeting of the Office of AIDS Research
Advisory Council (OARAC) will include the OAR Director's Report;
presentation and discussions on HIV and Aging, updates from the
Clinical Guidelines Working Groups of OARAC; an overview of ARPA-H;
updates from NIH HIV-related advisory councils and NIH-wide
programs; and public comment.
Place: Office of AIDS Research, 5601 Fishers Lane, Rockville, MD
20852 (Virtual Meeting).
Contact Person: Mary Glenshaw, Ph.D., MPH, OTR/L, Senior Science
Advisor, Office of AIDS Research, Office of the Director, National
Institutes of Health, 5601 Fishers Lane, Room 2E61, Rockville, MD
20852, (301) 496-0357, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: www.oar.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: February 1, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-02493 Filed 2-6-23; 8:45 am]
BILLING CODE 4140-01-P
